DUPIXENT 300 mg, solution for injection in a pre-filled syringe 2 syringes of 2 ml
Active ingredients: Dupilumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 2 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DUPIXENT 300 mg, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 seringue(s) préremplie(s) en verre siliconé(e) de 2 ml avec dispositif(s) de sécurité de l'aiguille
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jan 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64627916CIP73011664CIP133400930116647Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DUPILUMABsolution | 300 mg · une seringue préremplie de 2 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.